Any 0 3 0 3 O
stage 4 9 4 9 O
for 10 13 10 13 O
MGZL 14 18 14 18 B-cancer
and 19 22 19 22 O
PMBL 23 27 23 27 B-cancer

HIV 0 3 28 31 B-chronic_disease
negative 4 12 32 40 O

No 0 2 41 43 O
active 3 9 44 50 O
symptomatic 10 21 51 62 O
ischemic 22 30 63 71 B-chronic_disease
heart 31 36 72 77 I-chronic_disease
disease 37 44 78 85 I-chronic_disease
, 44 45 85 86 O
myocardial 46 56 87 97 B-chronic_disease
infarction 57 67 98 108 I-chronic_disease
or 68 70 109 111 O
congestive 71 81 112 122 B-chronic_disease
heart 82 87 123 128 I-chronic_disease
failure 88 95 129 136 I-chronic_disease
within 96 102 137 143 O
the 103 106 144 147 O
past 107 111 148 152 O
year 112 116 153 157 O

No 0 2 158 160 O
history 3 10 161 168 O
of 11 13 169 171 O
unrelated 14 23 172 181 O
( 24 25 182 183 B-cancer
non 25 28 183 186 I-cancer
- 28 29 186 187 I-cancer
lymphomatous 29 41 187 199 I-cancer
) 41 42 199 200 I-cancer
neoplasms 43 52 201 210 I-cancer
within 53 59 211 217 O
past 60 64 218 222 B-upper_bound
5 65 66 223 224 I-upper_bound
years 67 72 225 230 I-upper_bound
other 73 78 231 236 O
than 79 83 237 241 O
non 84 87 242 245 B-cancer
- 87 88 245 246 I-cancer
melanoma 88 96 246 254 I-cancer
skin 97 101 255 259 I-cancer
cancer 102 108 260 266 I-cancer
or 109 111 267 269 O
in 112 114 270 272 B-cancer
- 114 115 272 273 I-cancer
situ 115 119 273 277 I-cancer
cancer 120 126 278 284 I-cancer

No 0 2 285 287 O
other 3 8 288 293 O
serious 9 16 294 301 O
concomitant 17 28 302 313 O
medical 29 36 314 321 O
illnesses 37 46 322 331 O
or 47 49 332 334 O
uncontrolled 50 62 335 347 O
active 63 69 348 354 B-chronic_disease
infection 70 79 355 364 I-chronic_disease
that 80 84 365 369 O
would 85 90 370 375 O
jeopardize 91 101 376 386 O
the 102 105 387 390 O
patient 106 113 391 398 O
's 113 115 398 400 O
ability 116 123 401 408 O
to 124 126 409 411 O
receive 127 134 412 419 O
the 135 138 420 423 O
regimen 139 146 424 431 B-treatment
with 147 151 432 436 O
reasonable 152 162 437 447 O
safety 163 169 448 454 O

No 0 2 455 457 O
prior 3 8 458 463 B-treatment
systemic 9 17 464 472 I-treatment
chemotherapy 18 30 473 485 I-treatment

Non 0 3 486 489 O
- 3 4 489 490 O
Hodgkin 4 11 490 497 B-cancer
's 11 13 497 499 I-cancer
lymphomas 14 23 500 509 I-cancer

Not 0 3 510 513 O
pregnant 4 12 514 522 B-pregnancy
or 13 15 523 525 O
nursing 16 23 526 533 O

Patients 0 8 534 542 O
greater 9 16 543 550 O
than 17 21 551 555 O
or 22 24 556 558 O
equal 25 30 559 564 O
to 31 33 565 567 O
12 34 36 568 570 B-lower_bound
years 37 42 571 576 I-lower_bound
old 43 46 577 580 O

Tissue 0 6 581 587 O
blocks 7 13 588 594 O
from 14 18 595 599 O
patients 19 27 600 608 O
treated 28 35 609 616 O
in 36 38 617 619 O
extramural 39 49 620 630 O
sites 50 55 631 636 O
must 56 60 637 641 O
be 61 63 642 644 O
forwarded 64 73 645 654 O
to 74 76 655 657 O
the 77 80 658 661 O
NCI 81 84 662 665 O
for 85 88 666 669 O
analysis 89 97 670 678 O
of 98 100 679 681 O
bcl-2 101 106 682 687 B-cancer
by 107 109 688 690 O
IHC 110 113 691 694 B-treatment
and 114 117 695 698 O
other 118 123 699 704 O
markers 124 131 705 712 O
within 132 138 713 719 O
1 139 140 720 721 B-upper_bound
month 141 146 722 727 I-upper_bound
of 147 149 728 730 O
study 150 155 731 736 O
entry 156 161 737 742 O

bilirubin 0 9 743 752 B-clinical_variable
less 10 14 753 757 O
than 15 19 758 762 O
1.5 20 23 763 766 B-upper_bound
mg 24 26 767 769 I-upper_bound
/ 26 27 769 770 I-upper_bound
dl 27 29 770 772 I-upper_bound

greater 0 7 773 780 O
than 8 12 781 785 O
1,000 13 18 786 791 B-lower_bound
and 19 22 792 795 O
platelets 23 32 796 805 B-clinical_variable
greater 33 40 806 813 O
than 41 45 814 818 O
100,000 46 53 819 826 B-clinical_variable
) 53 54 826 827 O
unless 55 61 828 834 O
impairment 62 72 835 845 O
is 73 75 846 848 O
due 76 79 849 852 O
to 80 82 853 855 O
organ 83 88 856 861 O
involvement 89 100 862 873 O
by 101 103 874 876 O
lymphoma 104 112 877 885 B-cancer
or 113 115 886 888 O
immune 116 122 889 895 O
- 122 123 895 896 O
mediated 123 131 896 904 O
mechanism 132 141 905 914 O
caused 142 148 915 921 O
by 149 151 922 924 O
lymphoma 152 160 925 933 O

in 0 2 934 936 O
adults 3 9 937 943 O
: 9 10 943 944 O
serum 11 16 945 950 B-clinical_variable
creatinine 17 27 951 961 I-clinical_variable
less 28 32 962 966 O
than 33 37 967 971 O
or 38 40 972 974 O
equal 41 46 975 980 O
to 47 49 981 983 O
1.5 50 53 984 987 B-upper_bound
mg 54 56 988 990 I-upper_bound
/ 56 57 990 991 I-upper_bound
dl 57 59 991 993 I-upper_bound
or 60 62 994 996 O
creatinine 63 73 997 1007 B-clinical_variable
clearance 74 83 1008 1017 I-clinical_variable
greater 84 91 1018 1025 O
than 92 96 1026 1030 O
60 97 99 1031 1033 B-lower_bound
ml 100 102 1034 1036 I-lower_bound
/ 102 103 1036 1037 I-lower_bound
min 103 106 1037 1040 I-lower_bound

in 0 2 1041 1043 O
children 3 11 1044 1052 O
serum 12 17 1053 1058 B-clinical_variable
CR 18 20 1059 1061 I-clinical_variable
less 21 25 1062 1066 O
than 26 30 1067 1071 O
or 31 33 1072 1074 O
equal 34 39 1075 1080 O
to 40 42 1081 1083 O
age 43 46 1084 1087 B-age
- 46 47 1087 1088 O
adjusted 47 55 1088 1096 O
normal 56 62 1097 1103 O
( 63 64 1104 1105 O
age 64 67 1105 1108 O
12 68 70 1109 1111 B-lower_bound
to 71 73 1112 1114 O
15 74 76 1115 1117 O
maximum 77 84 1118 1125 O
serum 85 90 1126 1131 B-clinical_variable
creatinine 91 101 1132 1142 I-clinical_variable
1.2 102 105 1143 1146 B-upper_bound
mg 106 108 1147 1149 I-upper_bound
/ 108 109 1149 1150 I-upper_bound
dl 109 111 1150 1152 I-upper_bound
and 112 115 1153 1156 O
age 116 119 1157 1160 O
greater 120 127 1161 1168 O
than 128 132 1169 1173 O
15 133 135 1174 1176 O
maximum 136 143 1177 1184 O
serum 144 149 1185 1190 O
creatinine 150 160 1191 1201 O
1.5 161 164 1202 1205 B-upper_bound
mg 165 167 1206 1208 I-upper_bound
/ 167 168 1208 1209 I-upper_bound
dl 168 170 1209 1211 I-upper_bound
) 170 171 1211 1212 O

mediastinal 0 11 1213 1224 B-cancer
gray 12 16 1225 1229 I-cancer
zone 17 21 1230 1234 I-cancer
lymphoma 22 30 1235 1243 I-cancer

